News Updates
More Articles
- A Framework for Improving Maternity Healthcare in the US (and Elsewhere)
- Nonanimal Models for Preclinical Safety and Efficacy Workshops in Australia: Can They Provide the Assurance Necessary to Support First-in-Human Clinical Trials?
- Optimizing ASEAN Joint Assessment: Lessons from a Multistakeholder Pilot
- Informed Consent in West Africa: Bridging Regulatory Compliance and Cultural Diversity
- Perspective: Changes in Site Ownership Will Positively Impact Clinical Trial Operations
Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
The pandemic exposed significant disparity in the pharmaceutical global supply chain, largely due to the dependency of low- and middle-income countries (LMICs) on pharmaceutical manufacturing in more industrialized nations. To mitigate this inequity and ensure supply of medicinal products across the globe, manufacturing of medicinal products must be decentralized through establishing manufacturing sites in LMICs.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!